Herantis Pharma Oyj (HEL:HRTIS)
1.410
+0.010 (0.71%)
Apr 1, 2025, 5:58 PM EET
Herantis Pharma Oyj Statistics
Total Valuation
HEL:HRTIS has a market cap or net worth of EUR 28.43 million. The enterprise value is 26.32 million.
Market Cap | 28.43M |
Enterprise Value | 26.32M |
Important Dates
The last earnings date was Thursday, March 6, 2025.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HEL:HRTIS has 20.16 million shares outstanding. The number of shares has increased by 17.25% in one year.
Current Share Class | n/a |
Shares Outstanding | 20.16M |
Shares Change (YoY) | +17.25% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 11.99% |
Owned by Institutions (%) | 58.44% |
Float | 13.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.33 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.06
Current Ratio | 4.06 |
Quick Ratio | 4.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -837.83 |
Financial Efficiency
Return on equity (ROE) is -220.37% and return on invested capital (ROIC) is -136.88%.
Return on Equity (ROE) | -220.37% |
Return on Assets (ROA) | -67.45% |
Return on Invested Capital (ROIC) | -136.88% |
Return on Capital Employed (ROCE) | -259.53% |
Revenue Per Employee | n/a |
Profits Per Employee | -449,091 |
Employee Count | 11 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.45 |
52-Week Price Change | n/a |
50-Day Moving Average | 1.44 |
200-Day Moving Average | 1.48 |
Relative Strength Index (RSI) | 53.16 |
Average Volume (20 Days) | 13,486 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.03M |
Pretax Income | -4.94M |
Net Income | -4.94M |
EBITDA | n/a |
EBIT | -5.03M |
Earnings Per Share (EPS) | -0.25 |
Balance Sheet
The company has 2.14 million in cash and 30,000 in debt, giving a net cash position of 2.11 million or 0.10 per share.
Cash & Cash Equivalents | 2.14M |
Total Debt | 30,000 |
Net Cash | 2.11M |
Net Cash Per Share | 0.10 |
Equity (Book Value) | -243,000 |
Book Value Per Share | -0.01 |
Working Capital | 1.94M |
Cash Flow
Operating Cash Flow | -6.55M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HEL:HRTIS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.25% |
Shareholder Yield | -17.25% |
Earnings Yield | -17.38% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |